Stockscreener 앱 받기
0.407
17.63%
0.061
시간 외 거래:
.41
0.003
+0.74%
전일 마감가:
$0.346
열려 있는:
$0.35
하루 거래량:
706.81K
Relative Volume:
0.09
시가총액:
$2.74M
수익:
$54,200
순이익/손실:
$-22.30M
주가수익비율:
-0.0345
EPS:
-11.793
순현금흐름:
$-13.39M
1주 성능:
+24.01%
1개월 성능:
-21.14%
6개월 성능:
-90.62%
1년 성능:
-95.13%
1일 변동 폭
$0.35
$0.407
1주일 범위
$0.3024
$0.407
52주 변동 폭
$0.25
$17.80
Hcw Biologics Inc Stock (HCWB) Company Profile
명칭
Hcw Biologics Inc
전화
954-842-2024
주소
2929 N COMMERCE PKWY, MIRAMAR
Compare HCWB vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
0.407 | 2.33M | 54,200 | -22.30M | -13.39M | -11.79 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Hcw Biologics Inc 주식(HCWB)의 최신 뉴스
HCWB SEC FilingsHcw Biologics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
EV Market: What is HCW Biologics Incs revenue forecast2026 Performance Recap & Stepwise Trade Signal Implementation - baoquankhu1.vn
Trading Recap: Can HCW Biologics Inc stock double in the next yearDip Buying & Free High Return Stock Watch Alerts - baoquankhu1.vn
HCWB stock soars pre-market on positive research results for CAR-T cell therapy - MSN
Growth Recap: Will HCW Biologics Inc outperform tech stocksEarnings Risk Report & Expert Verified Stock Movement Alerts - baoquankhu1.vn
HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results - The Manila Times
HCW Biologics Q4 revenue drops sharply on license suspension - TradingView
HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
HCW Biologics (NASDAQ: HCWB) outlines immunotherapy pipeline, deals and IP - Stock Titan
HCW Biologics (NASDAQ: HCWB) 2025 loss, going concern and Nasdaq risk - Stock Titan
Hair-loss trial starts as HCW Biologics warns on funding runway - Stock Titan
HCW Biologics Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Growth Value: Is HCW Biologics Inc gaining market shareDividend Hike & Low Risk High Reward Trade Ideas - baoquankhu1.vn
HCWB Should I Buy - Intellectia AI
HCWB (HCW Biologics) PB Ratio : (As of Mar. 27, 2026) - GuruFocus
HCWB Technical Analysis & Stock Price Forecast - Intellectia AI
Forecast Cut: Will HCW Biologics Inc benefit from green energy policiesWeekly Stock Recap & Growth Oriented Trade Recommendations - baoquankhu1.vn
HCW Biologics highlights positive findings for CAR-T therapy manufacturing - MSN
HCW Biologics (HCWB) Projected to Post Earnings on Wednesday - Defense World
If You Invested $1,000 in Hcw Biologics Inc. (HCWB) - Stock Titan
HCW Biologics Grants Exclusive Worldwide License for HCW11-006 to Trimmune with $7M Upfront Payment and Future Royalties 1 - Minichart
HCW Biologics receives $7M upfront fee from China licensee By Investing.com - Investing.com South Africa
HCW Biologics Secures $7M License Deal for HCW11-006 - TipRanks
HCW Biologics Closes Exclusive Global License for HCW11-006, Receives Upfront Payment - TradingView
HCW Biologics receives $7M upfront fee from China licensee - Investing.com
[8-K] HCW Biologics Inc. Reports Material Event - Stock Titan
HCW Biologics Inc. Receives $7 Million Upfront License Fee from Beijing Trimmune Biotech for HCW11-006 Development and Commercialization Rights - Quiver Quantitative
Hcw Biologics Closes Exclusive Worldwide License For Hcw11-006 – A High Potential Fusion Immunotherapeutic - TradingView
New fusion immunotherapy deal brings HCW Biologics $7M upfront - Stock Titan
HCWB HCW Biologics (NASDAQ) +81% pre market 17 Mar 2026: CAR-T paper lifts volume - Meyka
HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances - Investing News Network
Small Cap Stocks To Keep An Eye OnMarch 16th - MarketBeat
HCW Biologics Inc. (HCWB) Stock: Science Advances Study Highlights Next-Gen CAR-T Manufacturing Strategy - parameter.io
HCW Biologics’ compound shows promise in CAR-T cell production By Investing.com - Investing.com Canada
Promising Pharmaceutical Stocks To Keep An Eye OnMarch 16th - MarketBeat
Trading Volume Surges in Biotech, Tech, and Energy Stocks | Market RecapNews and Statistics - IndexBox
HCW Biologics (HCWB) spikes 71% as micro-cap volatility returns after Nasdaq compliance and recent financing - Quiver Quantitative
HCW Biologics announces positive research results for CAR-T cell therapy - TipRanks
HCWB Stock Soars Pre-Market On Positive Research Results For CAR-T Cell Therapy - Asianet Newsable
HCW Biologics’ compound shows promise in CAR-T cell production - Investing.com
HCW Biologics reports positive CAR-T cell therapy research results By Investing.com - Investing.com Australia
HCW Biologics Announces Positive Research Results for CAR-T - GlobeNewswire
HCW Biologics (NASDAQ: HCWB) seeks approval for large warrant issuances and deep repricing - Stock Titan
HCW Biologics restructures obligations to regain Nasdaq compliance - MSN
Hedge Fund Moves: What is HCW Biologics Incs revenue forecastLayoff News & Low Risk Entry Point Tips - baoquankhu1.vn
AI Stocks: Will HCW Biologics Inc outperform tech stocksTrade Volume Report & Expert Curated Trade Ideas - baoquankhu1.vn
Buyout Rumor: Can HCW Biologics Inc stock double in the next yearWeekly Investment Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
AI Stocks: Is HCW Biologics Inc forming a breakout patternWeekly Gains Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
HCWB Earnings History & Surprises | EPS & Revenue Results | HCW BIOLOGICS INC (NASDAQ:HCWB) - ChartMill
HCW Biologics (NASDAQ: HCWB) seeks warrant approvals at Apr 27 meeting - Stock Titan
HCWB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Hcw Biologics Inc (HCWB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):